Atul D Abhyankar1, Ashok S Thakkar. 1. Shree B.D. Mehta Mahavir Heart Institute, Athwagate, Gujarat, India. atulda@hotmail.com
Abstract
INTRODUCTION: Immediate and acute stent recoil has been observed following balloon deflation in normal and diseased coronary arteries, and the degree varies by stent design. METHODS: A total of 19 patients, who underwent elective stent implantation for single de novo native coronary artery lesions, were enrolled: all patients treated with the biodegradable polymer-coated sirolimus-eluting cobalt-chromium coronary stent system (Supralimus-Core(®)). The immediate, acute and cumulative stent recoil was assessed by quantitative coronary angiography. The cumulative stent recoil was measured at 24 h of stent implantation. RESULTS: The absolute late loss due to recoil was found 0.08 ± 0.19 mm for Immediate Stent Recoil (ISR), 0.05 ± 0.21 mm for Acute Stent Recoil (ASR) and 0.11 ± 0.25 mm for Cumulative Stent Recoil (CSR) respectively. CONCLUSIONS: In vivo acute stent recoil of the Supralimus-Core(®) has higher radial strength compared to other available standard drug-eluting stents.
INTRODUCTION: Immediate and acute stent recoil has been observed following balloon deflation in normal and diseased coronary arteries, and the degree varies by stent design. METHODS: A total of 19 patients, who underwent elective stent implantation for single de novo native coronary artery lesions, were enrolled: all patients treated with the biodegradable polymer-coated sirolimus-eluting cobalt-chromium coronary stent system (Supralimus-Core(®)). The immediate, acute and cumulative stent recoil was assessed by quantitative coronary angiography. The cumulative stent recoil was measured at 24 h of stent implantation. RESULTS: The absolute late loss due to recoil was found 0.08 ± 0.19 mm for Immediate Stent Recoil (ISR), 0.05 ± 0.21 mm for Acute Stent Recoil (ASR) and 0.11 ± 0.25 mm for Cumulative Stent Recoil (CSR) respectively. CONCLUSIONS: In vivo acute stent recoil of the Supralimus-Core(®) has higher radial strength compared to other available standard drug-eluting stents.
Authors: Shuzou Tanimoto; Nico Bruining; Ron T van Domburg; David Rotger; Petia Radeva; Jurgen M Ligthart; Patrick W Serruys Journal: J Am Coll Cardiol Date: 2008-11-11 Impact factor: 24.094
Authors: P Serruys; P De Jaegere; M Bertrand; G Kober; J F Marquis; J Piessens; R Uebis; B Valeix; V Wiegand Journal: Cathet Cardiovasc Diagn Date: 1991-12
Authors: P de Jaegere; P W Serruys; G A van Es; M Bertrand; V Wiegand; J F Marquis; M Vrolicx; J Piessens; B Valeix; G Kober Journal: Cathet Cardiovasc Diagn Date: 1994-06
Authors: Shuzou Tanimoto; Patrick W Serruys; Leif Thuesen; Dariusz Dudek; Bernard de Bruyne; Bernard Chevalier; John A Ormiston Journal: Catheter Cardiovasc Interv Date: 2007-10-01 Impact factor: 2.692
Authors: Rogério Coutinho das Neves; Márcia Renata Mortari; Elisabeth Ferroni Schwartz; André Kipnis; Ana Paula Junqueira-Kipnis Journal: Toxins (Basel) Date: 2019-04-10 Impact factor: 4.546